ACUTE LEUKEMIAS XVII
Biology and Treatment Strategies

Munich, Germany - February 24-27, 2019

International Symposium

Selected Abstracts Acute Leukemias XVII for Oral Presentation

T U E S D A Y , February 26, 2019

16.30-17.30
MS IX: Prize Giving Ceremony

Lecture Hall III (Overflow Rooms LHs IV+V)

Co-Chairs:
J. Ritter, Münster, DE
U. Creutzig, Hannover, DE

 

16.40-17.10
3 Best of Free Contributions:

16.40-16.50
POSTER #3 (AML – Biology)
THE INTERRUPTION OF PPAγR/RXR FUNCTION BY PML-RARα OR TRIB3 SEPARATELY CAUSES DYSLIPIDEMIA IN NEWLY DIAGNOSED APL OR IN ANTI-APL TREATED PATIENTS
Ke Li ert al.
(Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100050, China)

16.50-17.00
POSTER #72 (Immunotherapy)
ANTI-HUMAN CD117 CAR T-CELLS EFFICIENTLY ELIMINATE HEMATOPOIETIC STEM AND CD117-POSITIVE AML CELLS
R. Myburgh et al.
(Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland)

17.00-17.10
POSTER #55 (AML – Therapy)
EXTRACELLULAR ATP AND CD39 REGULATES MITOCHONDRIAL FUNCTION AND CYTARABINE RESISTANCE THROUGH INTRINSIC PKA-PGC1 PATHWAY IN ACUTE MYELOID LEUKEMIA
N. Aroua et al.
(Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Equipe Labellisée LIGUE 2018, F-31037 Toulouse, France ; University of Toulouse, F-31077 Toulouse, France)